济川药业：8月22日召开董事会会议

Group 1 - The core point of the article is that Jichuan Pharmaceutical (SH 600566) held its 16th meeting of the 10th board of directors on August 22, 2025, to review the proposal for the 2025 semi-annual report [1] - For the year 2024, the revenue composition of Jichuan Pharmaceutical is as follows: 33.53% from heat-clearing and detoxifying products, 28.11% from pediatric products, 14.41% from digestive products, 9.94% from other industries, and 8.13% from respiratory products [1]